http://www.citiuspharma.com
Citius Pharmaceuticals, Inc. Company Intro
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, and prescription products. The company develops Mino-Lok, which is in Phase III clinical trials for the treatment and salvage of infected central venous catheters in patients with catheter related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction tissue expander infections following breast reconstructive surgeries; and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for the treatment of hemorrhoids. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Industry
Healthcare
Citius Pharmaceuticals, Inc. Headquaters
11 Commerce Drive
Cranford,07016
United States
Citius Pharmaceuticals, Inc. Share price
14 Sep 2022 09:00 GMT
$1.3000
-0.02 (-1.52 %)
Citius Pharmaceuticals, Inc. Market cap
$186.918 M
WMC RANKING
2023
Citius Pharmaceuticals, Inc. # 473
BiotechnologyLatest Citius Pharmaceuticals, Inc. News
31 Mar 2023
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Forecasted to ...
Citius Pharmaceuticals, Inc is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on...
31 Mar 2023
Citius Pharmaceuticals' spinoff plans advance
Maxim Group LLC will serve as financial advisor to its wholly owned subsidiary, Citius Acquisition Corp. Inc., in connection with the intended spinoff. The...
31 Mar 2023
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Forecasted to ...
Citius Pharmaceuticals, Inc is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on...
WMC Market Score
WMC Market to Revenue Score
Citius Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Citius Pharmaceuticals, Inc. | USD | $0 | $21,174 | $-21,070 | $1,869M | 473 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Citius Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Citius Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Citius Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Citius Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Citius Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Citius Pharmaceuticals, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
